2006•Unpublished venueRequires access

The Clinical Observation About Thalidomide+MP Treat Multipie Myeloma

Huiying Zhang

Abstract

Objective To evaluate the efficacy of Thalidomide+MP in the anaemia of multiple myeloma. Mothods Case-control study.One group received Thalidomide+MP, Thalidomide 25mg/d,p.o., d1～21.MP(Mel.10mg/㎡·d,p.o.,four days,Prep.2mg/kg·d,p.o.,four days ,for four weeks).the other group received MP,the method is alike.Result The increment of Thalidomide+MP was greater than in the control group.Conclusion Thalidomide+MP is more effective for the anaemia of multiple myeloma.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Thalidomide, Multiple myeloma, Medicine, Internal medicine, Gastroenterology